Dr. Reddy’s Lab launches Colesevelam HCI Tablets

10 Oct 2018 Evaluate

Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCI) Tablets in the United States market approved by the US Food and Drug Administration (USFDA).

The WELCHOL brand and generic had US sales of around $471 million MAT for the most recent twelve months ending in August 2018 according to IMS Health. Dr. Reddy's Colesevelam Hydrochloride Tablets is available in 625 mg with 180 count bottle size.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

5955.65 71.30 (1.21%)
28-May-2024 15:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.